US › Healthcare

Radiopharm Theranostics Limited American Depositary Shares (RADX)

US · Healthcare · Biotechnology

$0.96+7.85%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$1.4M

Net profit

$-28.6M

Net margin

-2,038.8%

Key statistics

Market cap

$13.6M

Forward P/E

0.0

P/B

0.81

Book value

$1.48

EPS (TTM)

$-3.64

52-week high

$10.63

52-week low

$0.82

50-day MA

$1.52

200-day MA

$3.63

Beta

0.89

Analyst view

Analysts rate Radiopharm Theranostics Limited American Depositary Shares a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $17.14.

Shareholding

Institutions

0.74%

Largest institutional holders

Fund	Stake
HSBC Holdings PLC	0.53%
VGI Partners Ltd	0.34%
PNC Financial Services Group Inc	0.17%
UBS Group AG	0.01%
Integrated Wealth Concepts LLC	0.01%
Rhumbline Advisers	0.00%
Stonepine Capital Management Llc	0.00%
Strategic Wealth Partners	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Radiopharm Theranostics Limited American Depositary Shares — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.